GGrantIndex
Sort

21,453 grants matching tuberculosis

Chemical Biology of Nitroxyl (HNO) in Bacillus Subtilis

$407,044
S Bruce King · Wake Forest University · R15 · FY2023 · GM

The role of lymphatic clearance in brain TB

$406,924
Matyas Sandor · University Of Wisconsin-Madison · R01 · FY2022 · NS

The role of lymphatic clearance in brain TB

$406,924
Matyas Sandor · University Of Wisconsin-Madison · R01 · FY2023 · NS

Oxygen Sensors and P450 Monooxygenases in Mycobacertium tuberculosis

$406,919
Paul R Ortiz De Montellano · University Of California, San Francisco · R01 · FY2007 · AI

Molecular Mechanisms of Transcription Initiation and DNA Repair

$406,874
Eric A Galburt · Washington University · R35 · FY2022 · GM

REGULATION OF GRANULOMA IN TUBERCULOSIS

$406,761
Temple University · R01 · FY2000 · HL

Molecular Genetics of Rhizobium Nodulation Plasmids

$406,623
Graham C Walker · Massachusetts Institute Of Technology · R01 · FY2019 · GM

Molecular Genetics of Rhizobium Nodulation Plasmids

$406,623
Graham C Walker · Massachusetts Institute Of Technology · R01 · FY2020 · GM

Manipulation of Macrophage Responses by M. Tuberculosis

$406,606
Jeffery S Cox · University Of California Berkeley · P01 · FY2007 · AI

"The molecular mechanisms of asymmetric cell division in mycobacteria."

$406,572
Elizabeth Hesper Rego · Yale University · R01 · FY2020 · AI

TUBERCULOSIS ELIMINATION AND LABORATORY

$406,564
Sandra Breitborde · Wisconsin Department Of Health Services · U52 · FY2008 · PS

RANDOMIZED HEPATITIS B VACCINE DELIVERY TRIAL FOR IDUS

$406,525
University Of California San Francisco · R01 · FY2000 · DA

A novel T7 phage display technology to detect sarcoidosis specific antigens

$406,509
Lobelia Samavati · Wayne State University · R01 · FY2023 · HL

Target Mycobacterium Protein Tyrosine Phosphatase B for Anti-Tuberculosis Agents

$406,500
Zhong-Yin Zhang · Indiana University Indianapolis · R56 · FY2010 · AI

PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis

$406,451
Serena Patricia Koenig · Brigham And Women'S Hospital · U01 · FY2025 · AI

"The molecular mechanisms of asymmetric cell division in mycobacteria."

$406,420
Elizabeth Hesper Rego · Yale University · R01 · FY2023 · AI

Molecular-genetic analysis of TB persistence and latency

$406,277
Rockefeller University · R01 · FY2005 · AI

Development of Piperidinols and Engelhardiones as Novel Antituberculosis Agents

$406,257
Dianqing Sun · University Of Hawaii At Hilo · R15 · FY2011 · AI

Antimycobacterial Mechanisms of Apoptosis in the Lung

$406,250
Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2006 · HL

Drug Targets for Tuberculosis

$406,091
Eric Joseph Rubin · Harvard School Of Public Health · R01 · FY2009 · AI

Familias En Accion: Educating & Changing Communities

$406,035
Patricia J Kelly · University Of Missouri Kansas City · R01 · FY2007 · NR

Impact of Diabetes and Hyperlipidemia on Host Defense

$405,938
Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2006 · HL

Mechanisms of mosquito midgut invasion by Plasmodium ookinetes

$405,900
Marcelo Jacobs-Lorena · Johns Hopkins University · R01 · FY2010 · AI

Firing up new treatments against Mycobacterium ulcerans disease (Buruli ulcer)

$405,900
Jacques H. Grosset · Johns Hopkins University · R01 · FY2010 · AI

Emory/Georgia TB Research Advancement Center (TRAC)

$405,779
Neel Rajnikant Gandhi · Emory University · P30 · FY2024 · AI